BLATON MEDICAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BLATON MEDICAL
Largest movements
- Cash -€3,723
down €3,723 (-51.5%), from €7,226 to €3,503
mainly Net result for the year (-€10,040) and Deferred charges and accrued income (-€1,343)
- Deferred charges and accrued income +€1,343
up €1,343 (+45.1%), from €2,977 to €4,320
- Receivables within one year -€883
no longer reported in 2025 (was €883)
- Profit (loss) carried forward -€10,040
down €10,040, from €4,801 to -€5,239
- Other debts +€4,958
new in 2025: €4,958
- Trade debts +€3,031
up €3,031 (+698%), from €434 to €3,466
- Tax, wage and social debts -€1,213
down €1,213 (-42.5%), from €2,851 to €1,638
- Gross operating margin -€15,455
down €15,455, from €9,599 to -€5,856
- Taxes -€1,318
down €1,318 (-89.2%), from €1,478 to €160
- Financial charges +€588
up €588 (+47.2%), from €1,245 to €1,833
- Other operating charges -€510
down €510 (-18.9%), from €2,701 to €2,191
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €11,086 | €7,823 | -€3,263 | -29.4% |
| Current assets | 29/58 | €11,086 | €7,823 | -€3,263 | -29.4% |
| Amounts receivable within one year | 40/41 | €883 | - | -€883 | |
| Other amounts receivable | 41 | €883 | - | -€883 | |
| Cash at bank and in hand | 54/58 | €7,226 | €3,503 | -€3,723 | -51.5% |
| Deferred charges and accrued income | 490/1 | €2,977 | €4,320 | +€1,343 | +45.1% |
| Total equity and liabilities | 10/49 | €11,086 | €7,823 | -€3,263 | -29.4% |
| Equity | 10/15 | €7,801 | -€2,239 | -€10,040 | |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Contributions outside capital | 11 | - | €3,000 | +€3,000 | |
| Other | 1109/19 | - | €3,000 | +€3,000 | |
| Profit (loss) carried forward | 14 | €4,801 | -€5,239 | -€10,040 | |
| Amounts payable | 17/49 | €3,285 | €10,062 | +€6,777 | +206% |
| Amounts payable within one year | 42/48 | €3,285 | €10,062 | +€6,777 | +206% |
| Trade debts | 44 | €434 | €3,466 | +€3,031 | +698% |
| Suppliers | 440/4 | €434 | €3,466 | +€3,031 | +698% |
| Taxes, remuneration and social security | 45 | €2,851 | €1,638 | -€1,213 | -42.5% |
| Taxes | 450/3 | €2,851 | €1,638 | -€1,213 | -42.5% |
| Other amounts payable | 47/48 | - | €4,958 | +€4,958 | |
| Other operating charges | 640/8 | €2,701 | €2,191 | -€510 | -18.9% |
| Gross operating margin | 9900 | €9,599 | -€5,856 | -€15,455 | |
| Operating profit (loss) | 9901 | €6,898 | -€8,047 | -€14,945 | |
| Financial income | 75/76B | €51 | - | -€51 | |
| Recurring financial income | 75 | €51 | - | -€51 | |
| Financial charges | 65/66B | €1,245 | €1,833 | +€588 | +47.2% |
| Recurring financial charges | 65 | €1,245 | €1,833 | +€588 | +47.2% |
| Profit (loss) for the period before taxes | 9903 | €5,704 | -€9,881 | -€15,585 | |
| Income taxes | 67/77 | €1,478 | €160 | -€1,318 | -89.2% |
| Profit (loss) for the period | 9904 | €4,226 | -€10,040 | -€14,266 | |
| Profit (loss) for the period to be appropriated | 9905 | €4,226 | -€10,040 | -€14,266 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.